Organon & Co reports results for the quarter ended in September 30 - Earnings Summary

Organon & Co.

01/11/2024 03:44

* Organon & Co  OGN.N  reported quarterly adjusted earnings
of 87
cents​​ per share for the quarter ended September 30, identical
to the same quarter last year.  The mean expectation of
eight analysts for the quarter was for earnings of 90 cents per
share. Wall Street expected results to range from 78 cents
to $1.11 per share.
    * Revenue rose 4.1% to $1.58 billion from a year ago;
analysts
expected $1.56 billion. 
    * Organon & Co's reported EPS for the quarter was $1.38​.
    * The company reported quarterly net income of $359 million.
    * Organon & Co shares had fallen by 6.3% this quarter and
gained 24.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 13.5%
in the last three months.​ 
    * In the last 30 days, four analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and 2 "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "hold"

Wall Street's median 12-month price target for Organon & Co is
$24.00 
This summary was machine generated from LSEG data November 1 at
03:44 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.90           0.87           Missed
 Jun. 30 2024      1.08           1.12           Beat
 Mar. 31 2024      0.97           1.22           Beat
 Dec. 31 2023      0.83           0.88           Beat